These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 335742)

  • 41. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
    Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
    Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Active protection of mice against Salmonella typhi by immunization with strain-specific porins.
    Isibasi A; Ortiz-Navarrete V; Paniagua J; Pelayo R; González CR; García JA; Kumate J
    Vaccine; 1992; 10(12):811-3. PubMed ID: 1333686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenic complexes obtained from Salmonella typhi-murium and Salmonella typhi Ty2 by the bacterial acetone powder method.
    Tato P; Flisser A; Gavilanes M; Molinari JL
    Ann Microbiol (Paris); 1979 Jan; 130 A(1):47-60. PubMed ID: 382951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune response to phospholipase-A fractions of Salmonella typhi on experimental typhoid infection in mice.
    Punj V; Matta H; Kanwar SS
    Acta Microbiol Pol; 1996; 45(3-4):261-7. PubMed ID: 9127481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The detection of antigenemia in typhoid patients at different periods in the course of the infection].
    Gorelov AL; Levina GA; Prozorovskiĭ SV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Dec; (12):33-6. PubMed ID: 2483481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effectiveness of oral immunization of white mice with a complex S. typhimurium antigen].
    Elkina SI; Zhukova LF; Sergeev VV; Vaneeva NP; Tsvetkova NV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Sep; (9):79-83. PubMed ID: 386669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Production of a complex chemical typhoid vaccine containing O-, Vi, and H-antigens].
    Gekker VD; Sergeeva NS
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan; 50(1):14-8. PubMed ID: 4780106
    [No Abstract]   [Full Text] [Related]  

  • 48. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
    Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
    Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of T cells, TNF alpha and IFN gamma in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro- Salmonella vaccines.
    Mastroeni P; Villarreal-Ramos B; Hormaeche CE
    Microb Pathog; 1992 Dec; 13(6):477-91. PubMed ID: 1363824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An Unmutated IgM Response to the Vi Polysaccharide of
    Pandya KD; Palomo-Caturla I; Walker JA; K Sandilya V; Zhong Z; Alugupalli KR
    J Immunol; 2018 Jun; 200(12):4078-4084. PubMed ID: 29743315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significance of Vi Negative Isolates of Salmonella Enterica Serovar Typhi.
    Haque A
    Adv Exp Med Biol; 2018; 1052():9-18. PubMed ID: 29785477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acquired immunity against mouse typhoid: genetic restriction and comparative efficacy of ribosomal and conventional vaccines.
    Nickol AD; Bonventre PF
    J Med Microbiol; 1981 Nov; 14(4):419-33. PubMed ID: 7031251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemically-modified crude endotoxins as possible typhoid vaccines.
    Pistole TG; Marcus S
    Immunol Commun; 1973; 2(1):43-56. PubMed ID: 4609894
    [No Abstract]   [Full Text] [Related]  

  • 54. Duration of appearance of Vi antigen and Salmonella typhi in blood and urine of infected models.
    Wang DM; Gu XH
    Chin Med J (Engl); 1991 Jan; 104(1):46-8. PubMed ID: 1879196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Protective properties of Vi-antigen preparations as dependent on their adhesin content].
    Alliluev AP; Kotel'nikova OV; Korneeva SA; Fish NG; Kulinich LI
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):21-6. PubMed ID: 2469269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Specific and Cross-reactive Plasmablast Response in Humans after Primary and Secondary Immunization with Vi Capsular Polysaccharide Typhoid Vaccine.
    Pakkanen SH; Kantele JM; Rombo L; Kantele A
    Scand J Immunol; 2017 Oct; 86(4):207-215. PubMed ID: 28675263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The role of H-antigen in postvaccinal immunity against typhoid and paratyphoid].
    Kheĭfets LB; Stanislavskiĭ ES; Levina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1974; 00(5):113-4. PubMed ID: 4218035
    [No Abstract]   [Full Text] [Related]  

  • 58. Two Novel
    Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
    Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. O-antigenic specificity of the protective supernatant factor from Salmonella typhimurium effective in S. typhimurium-infected mice.
    Plant JE; Glynn AA; Valtonen MV
    Parasite Immunol; 1980; 2(4):293-302. PubMed ID: 6164034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental study of the mixed (oral-intradermal) vaccination method in enteric diseases.
    Dimache G; Croitoru M; Dimache A
    Roum Arch Microbiol Immunol; 1996; 55(3):215-23. PubMed ID: 9256023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.